DK3787652T3 - Probiotisk Bifidobacterium breve-stamme og præparater omfattende denne stamme - Google Patents
Probiotisk Bifidobacterium breve-stamme og præparater omfattende denne stamme Download PDFInfo
- Publication number
- DK3787652T3 DK3787652T3 DK19723337.2T DK19723337T DK3787652T3 DK 3787652 T3 DK3787652 T3 DK 3787652T3 DK 19723337 T DK19723337 T DK 19723337T DK 3787652 T3 DK3787652 T3 DK 3787652T3
- Authority
- DK
- Denmark
- Prior art keywords
- strain
- preparations
- bifidobacterium breve
- probiotic bifidobacterium
- probiotic
- Prior art date
Links
- 241000186012 Bifidobacterium breve Species 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18170250 | 2018-05-01 | ||
PCT/EP2019/061161 WO2019211341A1 (en) | 2018-05-01 | 2019-05-01 | Probiotic bifidobacterium breve strain and compositions comprising said strain |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3787652T3 true DK3787652T3 (da) | 2022-10-03 |
Family
ID=62104145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK19723337.2T DK3787652T3 (da) | 2018-05-01 | 2019-05-01 | Probiotisk Bifidobacterium breve-stamme og præparater omfattende denne stamme |
Country Status (8)
Country | Link |
---|---|
US (1) | US11653689B2 (da) |
EP (1) | EP3787652B1 (da) |
KR (1) | KR20210005717A (da) |
CN (1) | CN112272561A (da) |
AU (1) | AU2019263623A1 (da) |
BR (1) | BR112020022241A2 (da) |
DK (1) | DK3787652T3 (da) |
WO (1) | WO2019211341A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111996153B (zh) * | 2020-09-18 | 2022-02-15 | 深圳市创新医学科技有限公司 | 一种短双歧杆菌及其应用 |
CN113025526B (zh) * | 2021-03-24 | 2022-09-27 | 江南大学 | 一株减少结肠病理损伤且具有缓解便秘作用的两歧双歧杆菌 |
CN113005066B (zh) * | 2021-03-31 | 2023-07-21 | 江苏蓝泽生物科技有限公司 | 抗过敏、增加免疫力、降血糖、降脂减肥的复合双歧杆菌制剂及其制备方法 |
WO2024136604A1 (ko) * | 2022-12-23 | 2024-06-27 | 유노비아 주식회사 | 비피도박테리움 브레베 균주 및 이를 포함하는 nad+ 및 총 nad 증진용 조성물 |
CN118384188A (zh) * | 2023-05-09 | 2024-07-26 | 广州百芮医疗科技有限公司 | 用于改善慢性肾脏病的乳酸菌菌株组成物及其应用 |
CN117122569A (zh) * | 2023-08-21 | 2023-11-28 | 江南大学 | 短双歧杆菌ccfm683缓解结直肠腺瘤的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0323039D0 (en) * | 2003-10-01 | 2003-11-05 | Danisco | Method |
ITMI20110679A1 (it) | 2011-04-20 | 2012-10-21 | Giovanni Mogna | Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica. |
US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
ITRM20110477A1 (it) * | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
-
2019
- 2019-05-01 EP EP19723337.2A patent/EP3787652B1/en active Active
- 2019-05-01 KR KR1020207034624A patent/KR20210005717A/ko active Search and Examination
- 2019-05-01 US US17/051,653 patent/US11653689B2/en active Active
- 2019-05-01 AU AU2019263623A patent/AU2019263623A1/en active Pending
- 2019-05-01 DK DK19723337.2T patent/DK3787652T3/da active
- 2019-05-01 CN CN201980039106.3A patent/CN112272561A/zh active Pending
- 2019-05-01 WO PCT/EP2019/061161 patent/WO2019211341A1/en active Search and Examination
- 2019-05-01 BR BR112020022241-0A patent/BR112020022241A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
US11653689B2 (en) | 2023-05-23 |
BR112020022241A2 (pt) | 2021-02-02 |
US20210153535A1 (en) | 2021-05-27 |
CN112272561A (zh) | 2021-01-26 |
KR20210005717A (ko) | 2021-01-14 |
AU2019263623A8 (en) | 2021-01-07 |
EP3787652A1 (en) | 2021-03-10 |
WO2019211341A1 (en) | 2019-11-07 |
AU2019263623A1 (en) | 2020-11-05 |
EP3787652B1 (en) | 2022-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3787652T3 (da) | Probiotisk Bifidobacterium breve-stamme og præparater omfattende denne stamme | |
SG11202010944RA (en) | Lactobacillus paracasei strain and use thereof | |
EP3798298A4 (en) | LACTOBACILLUS GASSERI KBL697 STRAIN AND ITS USE | |
DK3194567T3 (da) | Probiotiske Bifidobacterium adolescentis-stammer | |
DK3707159T5 (da) | Hidtil ukendte modificerede t-cellereceptorer og immunterapi med anvendelse deraf | |
EP3812452A4 (en) | BIFIDOBACTERIUM LACTIS BL-99 AND ITS USES | |
DK3596116T5 (da) | Variante immunmodulatoriske pd-l1-proteiner og anvendelser deraf | |
DK3386523T3 (da) | Bifidobacterium longum til behandling af fedme og associerede metabolske sygdomme | |
IL263238A (en) | Composition of probiotics and digestive enzymes and method of preparing and using the same | |
DK3554517T3 (da) | Probiotisk sammensætning omfattende lactobacillus rhamnosus og lactobacillus paracasei stammer | |
SG11202011820VA (en) | Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis | |
IL268704B (en) | Formulations of antibodies against human rankl, and methods of using them | |
EP3518971A4 (en) | ANTIBODIES AND THERAPEUTIC PROTEIN FORMULATIONS AND USES THEREOF | |
EP3798299A4 (en) | LACTOBACILLUS CRISPATUS KBL693 STRAIN AND USE THEREOF | |
EP4293103A4 (en) | BIFIDOBACTERIUM LACTIS AND ITS APPLICATION | |
MX2019004487A (es) | Metodos y composiciones para el tratamiento de la enfermedad de fabry. | |
IT201600091033A1 (it) | Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti. | |
DK3387156T3 (da) | Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme | |
SG11201608730UA (en) | Bifidobacterium breve cbt br3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same | |
PL3187175T3 (pl) | Suplementacyjne preparaty terapeutyczne do sekwencyjnego lub oddzielnego podawania kwasu masłowego i probiotyków | |
SG11202011146TA (en) | Drug-resistant immune cells and methods of use thereof | |
DK2802333T3 (da) | Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner | |
AU2019213029A8 (en) | Bifidobacterium longum NCIMB 41676 | |
EP3601525C0 (en) | PROBIOTIC LACTOBACILLUS CASEI STRAIN AND ITS USES | |
DK3426680T3 (da) | Aktivin type 2 receptor bindende proteiner og anvendelser deraf |